Jason Bock has extensive experience in the biopharmaceutical industry, with their most recent role as the CEO of CTMC, a joint venture between Resilience and MD Anderson Cancer Center. Prior to this, they served as the Vice President and Head of Biologics Product Development, Therapeutics Discovery at MD Anderson Cancer Center. Bock also held leadership positions at Teva Pharmaceuticals, including VP of Global CMC Biologics and Director of Pharmaceutical Development. Jason started their career at CoGenesys as a Senior Manager in Pharmaceutical Development and previously worked as a Senior Scientist in Process Development at Human Genome Sciences.
Jason Bock attended The Pingry School, although it is not specified when they attended or if they obtained any degree or field of study from there. Jason then went on to study Biology at the Massachusetts Institute of Technology, earning a Bachelor of Science (BS) degree from 1990 to 1994. Afterward, they pursued a PhD in Biochemistry at Stanford University School of Medicine from 1994 to 2000.
Org chart
Sign up to view 8 direct reports
Get started